Archive for April 2024
Septicyte RAPID, A New Biomarker For The Diagnosis Of Nosocomial Infections In ICU Polytrauma Patients
Independent Studies Presented at ESCMID Global Demonstrate the Clinical Utility of SeptiCyte® RAPID in Patients Suspected of Sepsis, Including in Polytrauma Patients
SeptiCyte® RAPID accurately differentiated between nosocomial infections and systemic inflammatory response syndrome in polytrauma ICU patients suspected of sepsis. SeptiScore® was elevated in ICU patients suspected of sepsis when a causative pathogen was identified. SEATTLE and BRISBANE, Australia, April 17, 2024 /PRNewswire/ — Immunexpress, Pty Ltd., a molecular diagnostic company focused on improving outcomes for suspected sepsis…
Read More